Top Markets
Coin of the day
Emcure Pharmaceuticals Ltd. Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

EMCURE
株式のランク #4303
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
株価
$20.55
時価総額
$3.90B
変化(1日)
0.83%
変化(1年)
22.65%
IN
取引 Emcure Pharmaceuticals Ltd. (EMCURE)

カテゴリー

Emcure Pharmaceuticals Ltd.(EMCURE)の株式分割履歴
Emcure Pharmaceuticals Ltd.株(シンボル:EMCURE)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 26, 2026に行われました。
Aug 26, 2026より前に購入されたEMCURE株は、現在0EMCURE株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割